Home › NDC Lookup › RxCUI directory › RxCUI 1040054

Dextromethorphan hydrobromide 20 MG / quinidine sulfate 10 MG Oral Capsule — RxCUI 1040054

RxNorm drug concept · Semantic clinical drug
RxCUI 1040054 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1040054
Official nameDextromethorphan hydrobromide 20 MG / quinidine sulfate 10 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdextromethorphan HBr 20 MG / quiNIDine sulfate 10 MG Oral Capsule
FDA products mapped3
Package NDCs mapped5
Reported Medicaid activity (SDUD)22,121 prescriptions · 42 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dextromethorphan and Quinidine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Yes — this medication is specifically approved just for pseudobulbar affect, or PBA. PBA is a condition where you laugh or cry suddenly, involuntarily, and often much more intensel...
  • What exactly is pseudobulbar affect, and is this medication just for that?
  • You'll start at one capsule a day for the first week, then move to one capsule every 12 hours after that. Some people notice an improvement within weeks of reaching the full dose,...
  • How long does it take to start working, and do I need to take it forever?
📖 Read our full Dextromethorphan and Quinidine guide →

🕸️ Concept Web — How Dextromethorphan hydrobromide 20 MG / quinidine... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Dextromethorphan hydrobromide 20 MG / quinidine sulfate 10 MG Oral Capsule RxCUI 1040054

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Dextromethorphan 3289
    • Quinidine 9068
    • Dextromethorphan / quinidine 1040053
    • Dextromethorphan hydrobromide 102490
    • Quinidine sulfate 9069
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Nuedexta 1040055
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dextromethorphan / quinidine Oral Capsule 1040052
    • Dextromethorphan hydrobromide / quinidine sulfate Oral Capsule 2647985
    • Dextromethorphan / quinidine Oral Product 1155217
    • Dextromethorphan / quinidine Pill 1155218
    • Dextromethorphan hydrobromide / quinidine sulfate Oral Product 2662146
    • Dextromethorphan hydrobromide / quinidine sulfate Pill 2663164
    • Dextromethorphan / quinidine Oral Capsule [Nuedexta] 1040057
    • Dextromethorphan hydrobromide / quinidine sulfate Oral Capsule [Nuedexta] 2657981
    • +5 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 18 of 23 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Dextromethorphan hydrobromide 20 MG SCDC · 1037200
  • Quinidine sulfate 10 MG SCDC · 1040051
  • Dextromethorphan / quinidine Oral Capsule SCDF · 1040052
  • Dextromethorphan hydrobromide / quinidine sulfate Oral Capsule SCDFP · 2647985
  • Dextromethorphan / quinidine Oral Product SCDG · 1155217
  • Dextromethorphan / quinidine Pill SCDG · 1155218
  • Dextromethorphan hydrobromide / quinidine sulfate Oral Product SCDGP · 2662146
  • Dextromethorphan hydrobromide / quinidine sulfate Pill SCDGP · 2663164

Brand-Name Concepts

  • Dextromethorphan hydrobromide 20 MG / quinidine sulfate 10 MG Oral Capsule [Nuedexta] SBD · 1040058
  • Dextromethorphan hydrobromide 20 MG / quinidine sulfate 10 MG [Nuedexta] SBDC · 1040056
  • Dextromethorphan / quinidine Oral Capsule [Nuedexta] SBDF · 1040057
  • Dextromethorphan hydrobromide / quinidine sulfate Oral Capsule [Nuedexta] SBDFP · 2657981
  • Nuedexta Oral Product SBDG · 1178798
  • Nuedexta Pill SBDG · 1178799
  • Nuedexta BN · 1040055

📦 FDA Products & Package NDCs

3 products · 5 package NDCs
5 package NDCs map to RxCUI 1040054 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
31722-0693-60 60 CAPSULE in 1 BOTTLE (31722-693-60) Dextromethorphan hydrobromide and quinidine sulfate Camber Pharmaceuticals, Inc. 2024-08-28
59148-0053-16 60 CAPSULE, GELATIN COATED in 1 BOTTLE (59148-053-16) Nuedexta Otsuka America Pharmaceutical, Inc 2023-01-03
59148-0053-98 4 CARTON in 1 BOX (59148-053-98) / 1 BOTTLE in 1 CARTON (59... Nuedexta Otsuka America Pharmaceutical, Inc 2023-01-03
64597-0301-13 1 BOTTLE in 1 CARTON (64597-301-13) / 13 CAPSULE, GELATIN C... NUEDEXTA Avanir Pharmaceuticals, Inc. 2010-12-01
64597-0301-60 60 CAPSULE, GELATIN COATED in 1 BOTTLE (64597-301-60) NUEDEXTA Avanir Pharmaceuticals, Inc. 2010-12-01
Observed labelers: Avanir Pharmaceuticals, Inc. (2) · Otsuka America Pharmaceutical, Inc (2) · Camber Pharmaceuticals, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.